recombinant human igfbp7 k95r protein (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
94
Structured Review
R&D Systems
recombinant human igfbp7 k95r protein
Recombinant Human Igfbp7 K95r Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/igfbp7/Recombinant+Human+IGFBP-rp1%2FIGFBP-7+(K95R)+Protein%2C+CF/pmc13046735-246-37-41
Average 94 stars, based on 10 article reviews
Recombinant Human Igfbp7 K95r Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/igfbp7/Recombinant+Human+IGFBP-rp1%2FIGFBP-7+(K95R)+Protein%2C+CF/pmc13046735-246-37-41
Average 94 stars, based on 10 article reviews
recombinant human igfbp7 k95r protein - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Recombinant:Article Title: Development and provisional validation of a multiplex LC-MRM-MS test for timely kidney injury detection in urine Article Snippet: Recombinant SLC22A2 (Cat. Nr. H00006582-P01) was from Abnova (Taipei, Taiwan). .. Recombinant nephrin (Cat. Nr. 9399-NN-050) and biotinylated polyclonal antibodies against human TIMP2 (Cat. Nr. BAF971), Article Title: IGFBP2 secretion by mammary adipocytes limits breast cancer invasion. Article Snippet: .. For the exogenous protein inverse invasion screen, cells were treated with either PBS or one of the following recombinant proteins (5 μM): SPARC (R&D Systems, 941-SP), DKK1 (R&D Systems, 5439-DK), DKK3 (R&D Systems, 1118-DK), TFPI (R&D Systems, 2974-PI), TFPI2 (R&D Systems, 2545-PI), HHIP (R&D Systems, 9280-HP), PAI1 (R&D Systems, 1786-PI), IGFBP2 (R&D Systems, 674-B2), Article Title: IGFBP2 secretion by mammary adipocytes limits breast cancer invasion Article Snippet: .. For the exogenous protein inverse invasion screen, cells were treated with either PBS or one of the following recombinant proteins (5 μM): SPARC (R&D Systems, 941-SP), DKK1 (R&D Systems, 5439-DK), DKK3 (R&D Systems, 1118-DK), TFPI (R&D Systems, 2974-PI), TFPI2 (R&D Systems, 2545-PI), HHIP (R&D Systems, 9280-HP), PAI1 (R&D Systems, 1786-PI), IGFBP2 (R&D Systems, 674-B2), Injection:Article Title: Delayed Administration of IGFBP7 Improved Bone Defect Healing via ZO‐1 Dependent Vessel Stabilization Article Snippet: To investigate the effects of IGFBP7 or AT1001 on vessel permeability in vivo, nude mice ( n = 6 per group) were subcutaneously injected with a mixture of human umbilical vein endothelial cells (1 × 10 7 ; HUVECs) and Matrigel (0.1 mL; Becton, Dickinson and Company, Franklin Lakes, NJ, USA) at 4 °C on ice to construct subcutaneous tumors. .. One day after inoculation, the experimental group animals were injected with Article Title: Delayed Administration of IGFBP7 Improved Bone Defect Healing via ZO-1 Dependent Vessel Stabilization. Article Snippet: The vascular response following injury is pivotal for successful bone-defect repair but constitutes a major hurdle in the field of regenerative medicine.. Throughout this process, vessel stabilization is crucial to provide an adequate nutrient supply and facilitate efficient waste removal.. Therefore, this study investigated whether promoting vascular stabilization improves bone defect repair outcomes. Control:Article Title: Delayed Administration of IGFBP7 Improved Bone Defect Healing via ZO‐1 Dependent Vessel Stabilization Article Snippet: To investigate the effects of IGFBP7 or AT1001 on vessel permeability in vivo, nude mice ( n = 6 per group) were subcutaneously injected with a mixture of human umbilical vein endothelial cells (1 × 10 7 ; HUVECs) and Matrigel (0.1 mL; Becton, Dickinson and Company, Franklin Lakes, NJ, USA) at 4 °C on ice to construct subcutaneous tumors. .. One day after inoculation, the experimental group animals were injected with Article Title: Delayed Administration of IGFBP7 Improved Bone Defect Healing via ZO‐1 Dependent Vessel Stabilization Article Snippet: .. The experimental group was treated with Article Title: Delayed Administration of IGFBP7 Improved Bone Defect Healing via ZO-1 Dependent Vessel Stabilization. Article Snippet: The vascular response following injury is pivotal for successful bone-defect repair but constitutes a major hurdle in the field of regenerative medicine.. Throughout this process, vessel stabilization is crucial to provide an adequate nutrient supply and facilitate efficient waste removal.. Therefore, this study investigated whether promoting vascular stabilization improves bone defect repair outcomes. Incubation:Article Title: Delayed Administration of IGFBP7 Improved Bone Defect Healing via ZO‐1 Dependent Vessel Stabilization Article Snippet: .. The experimental group was treated with Article Title: Delayed Administration of IGFBP7 Improved Bone Defect Healing via ZO-1 Dependent Vessel Stabilization. Article Snippet: The vascular response following injury is pivotal for successful bone-defect repair but constitutes a major hurdle in the field of regenerative medicine.. Throughout this process, vessel stabilization is crucial to provide an adequate nutrient supply and facilitate efficient waste removal.. Therefore, this study investigated whether promoting vascular stabilization improves bone defect repair outcomes. Saline:Article Title: Pluripotent stem cell-derived committed cardiac progenitors remuscularize damaged ischemic hearts and improve their function in pigs. Article Snippet: Total protein was run on 4–12% Bis-Tris NuPage Gel (Invitrogen, NP0323BOX) under reducing conditions at 120 V for 90min, protein was subsequently transferred to methanolactivated PVDF membrane at 75 V for 90 mins. .. Membranes were blocked in 5% (w/v) skim milk in Tris-buffered saline with Tween20 (TBST), after which membranes were stained for either MECR (Thermo Fisher Scientific, PA5-54555, RRID:AB_2643839, 1:250), GATA4 (Abcam, ab124265, RRID:AB_11000793, 1:1000), ISL1 (Abcam, 86472, RRID:AB_1951287, 1:1000), NKX2.5 (Santa Cruz Biotechnology, sc-14033, RRID:AB_650281, 1:250), MYH6 (Abcam, ab50967, RRID:AB_942084, 1:1000), SLC8A1 (Cell Signaling, 55075- 1-AP, RRID:AB_2881262, 1:1000), ACTN2 (Sigma, A7811, RRID:AB_476766, 1:1000), ACTC1 (Sigma, SAB5600071, 1:1000), ANKRD1/CARP (Millipore, MABS1228, 1:250), CRHBP (Sigma, HPA046120, RRID:AB_10959760, 1:1000), TNNT2 (Abcam, ab91605, RRID:AB_2050427, 1:5000), Staining:Article Title: Pluripotent stem cell-derived committed cardiac progenitors remuscularize damaged ischemic hearts and improve their function in pigs. Article Snippet: Total protein was run on 4–12% Bis-Tris NuPage Gel (Invitrogen, NP0323BOX) under reducing conditions at 120 V for 90min, protein was subsequently transferred to methanolactivated PVDF membrane at 75 V for 90 mins. .. Membranes were blocked in 5% (w/v) skim milk in Tris-buffered saline with Tween20 (TBST), after which membranes were stained for either MECR (Thermo Fisher Scientific, PA5-54555, RRID:AB_2643839, 1:250), GATA4 (Abcam, ab124265, RRID:AB_11000793, 1:1000), ISL1 (Abcam, 86472, RRID:AB_1951287, 1:1000), NKX2.5 (Santa Cruz Biotechnology, sc-14033, RRID:AB_650281, 1:250), MYH6 (Abcam, ab50967, RRID:AB_942084, 1:1000), SLC8A1 (Cell Signaling, 55075- 1-AP, RRID:AB_2881262, 1:1000), ACTN2 (Sigma, A7811, RRID:AB_476766, 1:1000), ACTC1 (Sigma, SAB5600071, 1:1000), ANKRD1/CARP (Millipore, MABS1228, 1:250), CRHBP (Sigma, HPA046120, RRID:AB_10959760, 1:1000), TNNT2 (Abcam, ab91605, RRID:AB_2050427, 1:5000), |